Results 191 to 200 of about 105,778 (287)

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Conditional Survival for Pancreas Graft and Its Associated Factors After Pancreas Transplantation. [PDF]

Ann Gastroenterol Surg
Tomimaru Y, Ito T, Kitamura T, Kenmochi T, Doki Y, Eguchi H.   +5 more
europepmc   +1 more source

Induction in Pancreas Transplantation: T-cell Depletion Versus IL-2 Receptor Blockade. [PDF]

Transplant Direct, 2022
Aziz F, Parajuli S, Kaufman D, Odorico J, Mandelbrot D.   +4 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Process Variation in Liver, Kidney, and Pancreas Transplantation: A Multicenter Evaluation From the Consortium for the Holistic Assessment of Risk in Transplant. [PDF]

Transplant Direct
Strauss AT, Caicedo JC, Welsh W, Reed RD, Gordon EJ, Taber D, Ng YH, Ross-Driscoll K, Schold JD, Serper M, Olson A, Harding JL, Adams A, Kirk AD, McElroy LM.   +14 more
europepmc   +1 more source

Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease. [PDF]

Fujita Med J, 2023
Fujisawa-Tanaka C, Hiratsuka I, Shibata M, Kurihara K, Aida N, Takayanagi T, Seino Y, Ito T, Kenmochi T, Suzuki A.   +9 more
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Donor after circulatory death in pancreas transplantation: a scoping review of the literature. [PDF]

Front Transplant
Chassot M, Scheen M, Wassmer CH, Compagnon P, Peloso A, Haidar F.   +5 more
europepmc   +1 more source

Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition. [PDF]

Am J Transplant, 2022
Stratta RJ, Farney AC, Fridell JA.
europepmc   +1 more source

Outcomes of pancreas transplantation over two decades: a single-center retrospective cohort study. [PDF]

Ann Surg Treat Res
Shin J, Woo HY, Jo EA, Cho A, Han A, Ahn S, Min S, Ha J.   +7 more
europepmc   +1 more source